{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T10:45:46Z","timestamp":1772621146421,"version":"3.50.1"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Reliable markers for predicting postoperative recurrence in high-risk stage II\u2013III colorectal cancer remain limited. Dynamic changes in immunoglobulin G (IgG) may provide prognostic information beyond carcinoembryonic antigen (CEA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This single-centre retrospective cohort study included 192 patients with high-risk stage II or III colorectal cancer who underwent curative resection between January 2021 and June 2023. The study evaluated whether dynamic postoperative monitoring of serum IgG predicts 2-year disease-free survival (DFS) compared with CEA. Serial IgG and CEA measurements within 24 months were categorised as favourable or unfavourable trajectories based on predefined thresholds and temporal trends. Patients were further stratified into four groups according to combined IgG and CEA dynamics. Survival was assessed using Kaplan\u2013Meier analysis and Cox regression models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 192 eligible patients, 60 (31.3%) experienced recurrence or death within 2 years. Unfavourable IgG trajectories (n=82) were associated with significantly lower 2-year DFS than favourable trajectories (55% [95% CI 44\u201365] vs 82% [95% CI 73\u201388], log-rank P&amp;lt;0.01). CEA trajectories showed only borderline separation (67% [95% CI 55\u201377] vs 79% [95% CI 71\u201385], log-rank P = 0.06). Patients with both unfavourable IgG and CEA trajectories had the poorest outcomes (2-year DFS 31% [95% CI 16\u201347]). In multivariable analysis, an unfavourable IgG trajectory independently predicted recurrence or death (HR 2.05, 95% CI 1.32\u20133.18), whereas CEA trajectory was not significant.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Dynamic postoperative IgG monitoring is independently associated with disease recurrence in high-risk stage II\u2013III colorectal cancer and offers incremental prognostic value beyond CEA. Incorporating serial IgG measurements may enhance postoperative risk stratification, although confirmation in prospective multicentre studies is warranted.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1753074","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T05:42:10Z","timestamp":1772602930000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Dynamic monitoring of immunoglobulin G as a prognostic indicator after curative resection in high-risk stage II\u2013III colorectal cancer: a retrospective cohort study"],"prefix":"10.3389","volume":"16","author":[{"given":"Junyi","family":"Sun","sequence":"first","affiliation":[{"name":"Medical Laboratory Center, Hebei Hospital of Traditional Chinese Medicine","place":["Shijiazhuang, Hebei, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Guo","sequence":"additional","affiliation":[{"name":"Nursing Profession, Hebei University of Chinese Medicine","place":["Shijiazhuang, Hebei, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinfang","family":"Guo","sequence":"additional","affiliation":[{"name":"Aonrectal Department 1, Hebei Hospital of Traditional Chinese Medicine","place":["Shijiazhuang, Hebei, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ni","family":"Wang","sequence":"additional","affiliation":[{"name":"Gastrointestinal Oncology Surgery, Hebei Hospital of Traditional Chinese Medicine","place":["Shijiazhuang, Hebei, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiangxue","family":"Feng","sequence":"additional","affiliation":[{"name":"Aonrectal Department 1, Hebei Hospital of Traditional Chinese Medicine","place":["Shijiazhuang, Hebei, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"499","DOI":"10.21147\/j.issn.1000-9604.2019.03.12","article-title":"Cancer IgG, a potential prognostic marker, promotes colorectal cancer progression","volume":"31","author":"Jiang","year":"2019","journal-title":"Chin J Cancer Res"},{"key":"B2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3390\/medsci13040229","article-title":"Evaluation of carcinoembryonic antigen as a prognostic marker for colorectal cancer relapse: insights from postoperative surveillance","volume":"13","author":"Titu","year":"2025","journal-title":"Med Sci (Basel)"},{"key":"B3","doi-asserted-by":"publisher","first-page":"28098","DOI":"10.1038\/srep28098","article-title":"Glycosylation of plasma IgG in colorectal cancer prognosis","volume":"6","author":"Theodoratou","year":"2016","journal-title":"Sci Rep"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-1867","article-title":"IgG glycome in colorectal cancer","volume":"22","author":"Vuckovic","year":"2016","journal-title":"Clin Cancer Res"},{"key":"B5","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1186\/s12885-025-14080-5","article-title":"Screening colorectal cancer associated autoantigens through multi-omics analysis and diagnostic performance evaluation of corresponding autoantibodies","volume":"25","author":"Qiu","year":"2025","journal-title":"BMC Cancer"},{"key":"B6","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s41392-024-01823-2","article-title":"Tumor biomarkers for diagnosis, prognosis and targeted therapy","volume":"9","author":"Zhou","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"B7","doi-asserted-by":"publisher","first-page":"4192","DOI":"10.1038\/s41598-024-54917-w","article-title":"Novel tumor marker index using carcinoembryonic antigen and carbohydrate antigen 19\u20139 is a significant prognostic factor for resectable colorectal cancer","volume":"14","author":"Kamada","year":"2024","journal-title":"Sci Rep"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.3390\/diagnostics14101001","article-title":"Unraveling the interplay of KRAS, NRAS, BRAF, and micro-satellite instability in non-metastatic colon cancer: A systematic review","volume":"14","author":"Orlandi","year":"2024","journal-title":"Diagn (Basel)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2020.11627","article-title":"Clinicopathological and mutational differences between tumors with multiple metastases and single lung metastasis in colorectal cancer","volume":"20","author":"Yanai","year":"2020","journal-title":"Oncol Lett"},{"key":"B10","doi-asserted-by":"publisher","first-page":"382","DOI":"10.3390\/biom10030382","article-title":"Reprogramming the constant region of immunoglobulin G subclasses for enhanced therapeutic potency against cancer","volume":"10","author":"Kang","year":"2020","journal-title":"Biomolecules"},{"key":"B11","doi-asserted-by":"publisher","first-page":"11597","DOI":"10.3390\/ijms222111597","article-title":"Cancer-cell-derived igG and its potential role in tumor development","volume":"22","author":"Kdimati","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B12","doi-asserted-by":"publisher","first-page":"526","DOI":"10.3892\/ol.2021.12787","article-title":"Prognostic and immunological roles of Fc fragment of IgG binding protein in colorectal cancer","volume":"22","author":"Zhuang","year":"2021","journal-title":"Oncol Lett"},{"key":"B13","doi-asserted-by":"publisher","first-page":"17562848241307601","DOI":"10.1177\/17562848241307601","article-title":"Mediation role of body mass index in the relationship between food-specific serum immunoglobulin G reactivity and colorectal adenomas in a Chinese population: a cross-sectional study","volume":"17","author":"Sun","year":"2024","journal-title":"Ther Adv Gastroenterol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"106341","DOI":"10.4240\/wjgs.v17.i7.106341","article-title":"Effect of graded nutritional intervention on elderly colorectal cancer patients\u2019 postop status","volume":"17","author":"Ni","year":"2025","journal-title":"World J Gastrointest Surg"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1172\/JCI153454","article-title":"An Asia-specific variant of human IgG1 represses colorectal tumorigenesis by shaping the tumor microenvironment","volume":"132","author":"Yang","year":"2022","journal-title":"J Clin Invest"},{"key":"B16","doi-asserted-by":"publisher","first-page":"7616","DOI":"10.1038\/s41598-023-34855-9","article-title":"Clinical implication of tissue carcinoembryonic antigen expression in association with serum carcinoembryonic antigen in colorectal cancer","volume":"13","author":"Aldilaijan","year":"2023","journal-title":"Sci Rep"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.758509","article-title":"Early postoperative serum carcinoembryonic antigen is a stronger independent prognostic factor for stage II colorectal cancer patients than T4 stage and preoperative CEA","volume":"11","author":"Fenqi","year":"2021","journal-title":"Front Oncol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.21037\/tcr.2019.11.27","article-title":"Postoperative carcinoembryonic antigen (CEA) levels predict outcomes after resection of colorectal cancer in patients with normal preoperative CEA levels","volume":"9","author":"Zhang","year":"2020","journal-title":"Transl Cancer Res"},{"key":"B19","doi-asserted-by":"publisher","first-page":"28044","DOI":"10.1038\/srep28044","article-title":"Prognostic values of four Notch receptor mRNA expression in gastric cancer","volume":"6","author":"Wu","year":"2016","journal-title":"Sci Rep"},{"key":"B20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12957-025-03662-z","article-title":"Prognostic value and clinicopathological significance of pre-and post-treatment systemic immune-inflammation index in colorectal cancer patients: a meta-analysis","volume":"23","author":"Tan","year":"2025","journal-title":"World J Surg Oncol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"8441","DOI":"10.3390\/ijms25158441","article-title":"Inflammation and colorectal cancer: A meta-analysis of the prognostic significance of the systemic immune-inflammation index (SII) and the systemic inflammation response index (SIRI)","volume":"25","author":"Menyhart","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B22","doi-asserted-by":"publisher","first-page":"101140","DOI":"10.1016\/j.neo.2025.101140","article-title":"Sialylated IgG-activated integrin beta4-Src-Erk axis stabilizes c-Myc in a p300 lysine acetyltransferase-dependent manner to promote colorectal cancer liver metastasis","volume":"61","author":"Chen","year":"2025","journal-title":"Neoplasia"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.21037\/tcr-23-1289","article-title":"Prognostic value of preoperative combined with postoperative systemic immune-inflammation index for disease-free survival after radical rectal cancer surgery: a retrospective cohort study","volume":"13","author":"Sun","year":"2024","journal-title":"Transl Cancer Res"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1193962","article-title":"Prognostic significance of systemic immune-inflammation index in patients with ovarian cancer: a meta-analysis","volume":"13","author":"Mao","year":"2023","journal-title":"Front Oncol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"7514","DOI":"10.3390\/jcm11247514","article-title":"Prognostic value of systemic immune-inflammation index (SII) in patients with glioblastoma: A comprehensive study based on meta-analysis and retrospective single-center analysis","volume":"11","author":"Yang","year":"2022","journal-title":"J Clin Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"106140","DOI":"10.1016\/j.isci.2023.106140","article-title":"Altered B cell immunoglobulin signature exhibits potential diagnostic values in human colorectal cancer","volume":"26","author":"Liu","year":"2023","journal-title":"iScience"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.692","article-title":"Multiplex determination of serological signatures in the sera of colorectal cancer patients using hydrogel biochips","volume":"5","author":"Butvilovskaya","year":"2016","journal-title":"Cancer Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3390\/genes16030275","article-title":"Clinical implications of cell-free DNA in managing BRAF V600E mutation-positive colorectal cancer","volume":"16","author":"Iwai","year":"2025","journal-title":"Genes (Basel)"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.852044","article-title":"Circulating glycan monosaccharide composite-based biomarker diagnoses colorectal cancer at early stages and predicts prognosis","volume":"12","author":"Li","year":"2022","journal-title":"Front Oncol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"106670","DOI":"10.3748\/wjg.v31.i18.106670","article-title":"Personalized surveillance in colorectal cancer: Integrating circulating tumor DNA and artificial intelligence into post-treatment follow-up","volume":"31","author":"Negoi","year":"2025","journal-title":"World J Gastroenterol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.7150\/jca.111828","article-title":"Predictive and prognostic biomarkers of recurrence in locoregional colorectal cancer","volume":"16","author":"Cendra","year":"2025","journal-title":"J Cancer"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1753074\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T05:42:11Z","timestamp":1772602931000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1753074\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,4]]},"references-count":31,"alternative-id":["10.3389\/fonc.2026.1753074"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1753074","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,4]]},"article-number":"1753074"}}